The most widely known “Rule of 5” is Lipinski’s Rule of Five, a set of guidelines used in drug development to predict whether a new compound will be absorbed well enough to work as an oral medication. The term also appears in nutrition, where a 5-to-1 ratio helps identify genuinely whole-grain packaged foods. Here’s what each version means and how it’s actually used.
Lipinski’s Rule of Five in Drug Discovery
In the late 1990s, pharmaceutical scientist Christopher Lipinski analyzed thousands of existing drugs and noticed a pattern: compounds that the body absorbs well after swallowing tend to share four physical and chemical traits. He packaged these traits into a simple screening tool now called the Rule of Five (sometimes written as “Ro5”). The name comes from the fact that each cutoff is a multiple of five.
A compound is predicted to have poor absorption or poor ability to cross cell membranes when any of the following are true:
- Molecular weight is greater than 500
- Fat solubility (logP) is greater than 5
- Hydrogen-bond donors number more than 5
- Hydrogen-bond acceptors number more than 10
In plain terms, the rule says a drug molecule needs to be small enough, not too greasy or too water-loving, and not too “sticky” with surrounding water molecules. If a molecule is too large or clings too tightly to water, it struggles to pass through the fatty membranes lining your gut and enter your bloodstream.
Why These Four Properties Matter
Your intestinal wall is essentially a barrier of fatty cell membranes. For a drug to reach your bloodstream after you swallow it, the molecule has to dissolve in your gut fluid, then slip through those fatty layers. Each of Lipinski’s four criteria addresses a different part of that journey.
Molecular weight is a rough proxy for size. Bigger molecules have a harder time squeezing between or through cells. Fat solubility (measured as logP) reflects how well a molecule dissolves in fats versus water. Too high and the drug gets trapped in fatty tissue; too low and it can’t cross cell membranes at all. Hydrogen-bond donors and acceptors describe how strongly a molecule interacts with water. A molecule covered in water-attracting spots won’t easily let go of the watery environment in your gut to pass into the fatty membrane.
When Drugs Break the Rule
The Rule of Five is a guideline, not a law. Plenty of successful oral drugs violate one or more of the criteria. Researchers now use the term “beyond Rule of Five” (bRo5) for these exceptions, and they include some important medications.
Cyclosporine, an immune-suppressing drug used after organ transplants, has a molecular weight of about 1,200, more than double the 500 cutoff. The antibiotic rifampicin, the antifungal itraconazole, and the cancer chemotherapy drug paclitaxel all exceed at least one Ro5 threshold yet still work as oral medications. HIV protease inhibitors like saquinavir, with a molecular weight near 670, were designed to fit into unusually large, complex binding sites on their target, which essentially demands a bigger molecule.
Many of these rule-breakers are natural products or inspired by natural products. Molecules like cyclosporine are macrocycles, ring-shaped structures that can fold in on themselves, hiding their water-loving groups and effectively “shrinking” to sneak through membranes. This trick lets them behave as if they were smaller and less polar than their raw numbers suggest.
The takeaway for drug development: the Rule of Five is most useful as an early filter. It reliably flags molecules that will probably fail, but passing the test doesn’t guarantee success, and failing it doesn’t make a compound hopeless.
How Drug Companies Use the Rule
In early-stage drug discovery, researchers often screen millions of candidate molecules using computer models. The Rule of Five acts as a first-pass filter to narrow that list. Compounds that violate two or more criteria are typically deprioritized unless there’s a strong reason to keep them, such as targeting a disease where no Ro5-compliant drug has worked.
The rule was never intended to define what “can” become a drug. It was derived by looking at patterns in existing drugs and predicting which new candidates are most likely to be absorbed orally. Compounds intended for injection, inhalation, or topical use don’t need to pass through the gut at all, so the Rule of Five doesn’t apply to them.
The 5-to-1 Rule for Packaged Foods
Outside of pharmacology, “rule of 5” sometimes refers to a quick nutrition trick for evaluating packaged grain products. The idea is simple: divide the total grams of carbohydrates on the nutrition label by the grams of dietary fiber. If the result is 5 or less, the product is likely a genuinely whole-grain food rather than a refined product with a misleading “whole wheat” label.
For example, a loaf of whole-wheat bread listing 20 grams of carbohydrates and only 2.7 grams of fiber per serving gives a ratio of about 7.4, which fails the test. A sprouted-grain bread with 15 grams of carbohydrates and 3 grams of fiber hits a ratio of exactly 5, passing the cutoff. The logic is that intact whole grains naturally contain fiber in roughly this proportion, so a high ratio signals that most of the grain’s fiber has been stripped away during processing.
This shortcut isn’t perfect. Some products add isolated fiber to improve the ratio without being truly whole grain, and some naturally low-fiber grains like white rice won’t fit the model. But as a quick check in the grocery aisle, it’s a practical way to compare breads, cereals, and crackers without decoding ingredient lists.